It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2012.
2012 | Hyderabad, Telangana, India | Under LiquidationAriston Pharma Nova Tech Private Limited, a under liquidation private limited company, was established on 19 October 2012 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232TG2012PTC083734. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹6.70 M.
It upholds a compliant status. Employing 24 professional, Its leadership includes Vedprakash Vyas (Director), Rajesh Chillale (Irp/Rp/Liquidator), Subhash Goverdhandasji Bissa (Director). Past directors included Viswanath Konala, Algatoori Bhavani, Srinivas Korkonda. It holds ₹6.09 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2019, with the balance sheet filed on 31 March 2019. It is based at D No.5-5-35/136/B, Ground Floor Prasanthi Nagar, Ida, Kukatpally, Hyderabad, Telangana, 500072.
U24232TG2012PTC083734
083734
19 October 2012
₹1.00 Cr
₹6.70 M
Roc Hyderabad
Unlisted
Under Liquidation
Explore comprehensive insights into Ariston Pharma Nova Tech Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vedprakash Vyas | Director | 19 Oct 2012 | Current |
| Rajesh Chillale | Irp/Rp/Liquidator | 24 May 2024 | Current |
| Subhash Goverdhandasji Bissa | Director | 25 Sep 2019 | Current |
| Shankar Sharma | Director | 16 Oct 2024 | Current |
| Rounak Sharma | Director | 16 Oct 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 30 Mar 2014 | Past |
| Pramod Abcsdd | Director | 20 Sep 2017 | Past |
| Pramod Abcsdd | Director | 25 Mar 2013 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Director | 25 Sep 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Ariston Pharma Nova Tech Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 46.56% decrease. The company also saw a substantial fall in profitability, with a 75.75% decrease in profit. The company's net worth moved up by a moderate rise of 3.26%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Ariston Pharma Nova Tech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹60,940,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Mar 2017 | Syndicate Bank | ₹0.94 M | Open |
| 09 Nov 2015 | Syndicate Bank | ₹6.00 Cr | Open |
Explore comprehensive loan charge details -
Ariston Pharma Nova Tech has a workforce of 24 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Ariston Pharma Nova Tech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ariston Pharma Nova Tech's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Shankar Sharma was appointed as a Director was appointed as a Director on 16 Oct 2024 & has been associated with this company since 1 year 2 months . was recorded as a recent event.
Rounak Sharma was appointed as a Director was appointed as a Director on 16 Oct 2024 & has been associated with this company since 1 year 2 months . was recorded as a recent event.
Progress on Rajesh Chillale was appointed as a IRP/RP/Liquidator was appointed as a IRP/RP/Liquidator on 24 May 2024 & has been associated with this company since 1 year 7 months . was documented.
The activity Ariston Pharma Nova Tech Private Limited last Annual general meeting of members was held on 30 Sep 2019 as per latest MCA records. was completed.
Progress on Subhash Goverdhandasji Bissa was appointed as a Director was appointed as a Director on 25 Sep 2019 & has been associated with this company since 6 years 3 months . was documented.
Progress on Ariston Pharma Nova Tech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Hyderabad. was documented.
The CIN of Ariston Pharma Nova Tech Private Limited is U24232TG2012PTC083734.
Ariston Pharma Nova Tech Private Limited is headquartered at D No.5-5-35/136/B, Ground Floor Prasanthi Nagar, Ida, Kukatpally, Hyderabad, Telangana, 500072.
Ariston Pharma Nova Tech Private Limited was incorporated on 19 October 2012.
The current directors of Ariston Pharma Nova Tech Private Limited are
The primary industry of Ariston Pharma Nova Tech Private Limited is Manufacturing.
Ariston Pharma Nova Tech Private Limited is unlisted.
The authorized capital of Ariston Pharma Nova Tech Private Limited is ₹1.00 Cr, and the paid-up capital is ₹6.70 M.
The compliance status of Ariston Pharma Nova Tech Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX